NCT07598058 PPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness Registry
| NCT ID | NCT07598058 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CorEvitas |
| Condition | Chronic Hand Eczema |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2026-07-21 |
| Primary Completion | 2099-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2026-07-21 with a primary completion date of 2099-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The design is a prospective, observational registry for subjects with CHE under the care of dermatology or other qualified healthcare provider. Longitudinal data are collected from both subjects and their treating provider during routine clinical encounters using a structured and standardized data collection method
Eligibility Criteria
Inclusion Criteria: * To be eligible to participate in this registry, an individual must meet all of the following criteria: 1. Diagnosed with moderate-to-severe CHE by a dermatologist or other qualified healthcare provider at the time of enrollment and initiating an eligible medication. 2. Is at least 18 years of age or older and has attained the legal age for consent to procedures involved in the research, under the applicable law of the jurisdiction in which the research is being conducted at the time of enrollment 3. Is willing and able to consent to participation in the registry 4. Is willing and able to complete registry-related forms electronically via personal devices. 5. Is willing and able to provide the information (first name, last name, email address, language and primary time zone) required to create an account to allow you to complete registry forms via a personal device; 6. Is willing and able to provide Personal Information (full legal name, sex, date of birth, home address zip or postal code and email address or phone number at a minimum) if required based on registry location and applicable laws and regulations. Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in the registry: 1\) Is participating or planning to participate in a blinded clinical trial for a CHE drug
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07598058 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Hand Eczema. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07598058 currently recruiting?
Yes, NCT07598058 is actively recruiting participants. Contact the research team at CHEregistry@thermofisher.com for enrollment information.
Where is the NCT07598058 trial being conducted?
This trial is being conducted at Waltham, United States.
Who is sponsoring the NCT07598058 clinical trial?
NCT07598058 is sponsored by CorEvitas. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.